Healthcare -
Biotechnology - NASDAQ - US
$ 15.135
-2.29 %
$ 1.28 B
Market Cap
-9.34
P/E
LQDA - STOCK-BASED COMPENSATION
Stock-based Compensation LQDA - Liquidia Corporation
10.1 M
LAST VALUE
22.29%
2 YEAR CAGR
35.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR